Interestingly, yeast-induced PRR stimulation of T cells might induce relevant phenotypes to cancer immunotherapy, with for example studies showing that TLR2 stimulation can improve T cell anti-cancer phenotypes105, lower antigen density thresholds for T cell activation106, and improve CAR T cell responses107. This evidence concerns the gene TLR2 and cancer.